-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Upgrades Bristol-Myers Squibb to Buy, Announces $75 Price Target

Benzinga·08/05/2026 14:20:25
Listen to the news
Argus Research analyst Jasper Hellweg upgrades Bristol-Myers Squibb (NYSE:BMY) from Hold to Buy and announces $75 price target.